Ampio Starts Patient Enrollment in its Ampion COVID-19 Program
- Thursday, July 23, 2020, 7:13
- PR Newswire
- Add a comment
ENGLEWOOD, Colo., July 23, 2020 /PRNewswire/ — Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company” or “Ampio”), is a biopharmaceutical company focused on the development and advancement of immunology-based therapies for prevalent inflammatory conditions. As part of this…
About the Author
admin has written 21717 stories on this site.